Ranking results:

Past rankings:

2020
Criterium:	Position:
Overall Score:	200-300
Total Project Funding per Partner:	300-400
Total Number of Projects:	200-300
2019
Criterium:	Position:
Overall Score:	100-200
Total Project Funding per Partner:	100-200
Total Number of Projects:	100-200
2018
Criterium:	Position:
Overall Score:	300-400
Total Project Funding per Partner:	700-800
Total Number of Projects:	700-800
Networking Rank (Reputation):	100-200
2017
Criterium:	Position:
Overall Score:	300-400
Total Project Funding per Partner:	300-400
Total Number of Projects:	400-500
Networking Rank (Reputation):	300-400
2016
Criterium:	Position:
Overall Score:	200-300
Total Project Funding per Partner:	100-200
Total Number of Projects:	200-300
Networking Rank (Reputation):	500-600

Ranking timeline:

Project Participation Performance(2016-01-01 - 2022-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 75
As coordinator: 14
As participant: 55
Sole participant: 6
Coordinator / Participant Ratio: 0.25^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2021	7.832.226	55.809.575	7.484.613	2	12
2020	6.619.072	49.825.857	5.810.830	6	9
2019	22.176.012	102.675.617	13.460.793	4	14
2018	6.527.723	4.250.370	2.055.111	2	2
2017	5.407.488	50.188.027	2.853.901	2	4
2016	18.344.566	62.382.604	10.689.862	4	14

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	13
STICHTING VU	12
JANSSEN PHARMACEUTICA NV	11
KAROLINSKA INSTITUTE	10
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	9
KATHOLIEKE UNIVERSITEIT LEUVEN	9
NOVARTIS PHARMA	8
UNIVERSITY COLLEGE LONDON	8
ACADEMISCH ZIEKENHUIS GRONINGEN	7
REGION HOVEDSTADEN	7
UNIVERSITEIT GENT	7
UNIVERSITY OF CAMBRIDGE	7
KING'S COLLEGE LONDON	6
PFIZER LIMITED	6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	6
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	6
UNIVERSITE DE GENEVE	6
UNIVERSITY OF HELSINKI	6
CHARITE UNIVERSITAETSMEDIZIN BERLIN	5
EUROPEAN CANCER PATIENT COALITION	5
F HOFFMANNLA ROCHE	5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	5
MEDIZINISCHE UNIVERSITAET WIEN	5
STICHTING LYGATURE	5
TAKEDA DEVELOPMENT CENTRE EUROPE	5
TAKEDA PHARMACEUTICALS INTERNATIONAL	5
UNIVERSITY OF NEWCASTLE UPON TYNE	5
UNIVERSITY OF OSLO	5
VRIJE UNIVERSITEIT BRUSSEL	5
ACADEMIC MEDICAL CENTRE AMSTERDAM	4
ALZHEIMER EUROPE	4
BAYER	4
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS	4
ELI LILLY AND COMPANY LIMITED	4
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V	4
OSPEDALE PEDIATRICO BAMBINO GESU	4
THE UNIVERSITY OF NOTTINGHAM	4
UNIVERSITAETSKLINIKUM FREIBURG	4
UNIVERSITY OF BOLOGNA	4
UNIVERSITY OF COPENHAGEN	4
UPPSALA UNIVERSITET	4
VIB VZW	4
VRIJE UNIVERSITEIT AMSTERDAM VERENIGING VOOR CHRISTELIJK WETENSCHAPPELIJK ONDERWIJS	4
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM	3
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG	3
CELGENE MANAGEMENT SARL	3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	3
EUROPEAN HEMATOLOGY ASSOCIATION	3
EUROPEAN MOLECULAR BIOLOGY LABORATORY	3
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA	3
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS	3
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON	3
FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA	3
GMV SOLUCIONES GLOBALES INTERNET SAU	3
GOETEBORGS UNIVERSITET	3
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT	3
H LUNDBECK AS	3
LEIDEN UNIVERSITY	3
LEIDS UNIVERSITAIR MEDISCH CENTRUM	3
LONDON SCHOOL OF ECONOMICS AND POLITICAL SCIENCE	3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN	3
MASARYKOVA UNIVERZITA	3
NOVO NORDISK	3
PROVINCIA LOMBARDO VENETA ORDINEOSPEDALIERO DI SAN GIOVANNI DI DIO FATEBENEFRATELLI	3
RUPRECHT KARLS UNIVERSITAET HEIDELBERG	3
SANOFIAVENTIS	3
SVEUCILISTE U SPLITU MEDICINSKI FAKULTET	3
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL	3
UNIVERSIDAD DE NAVARRA	3
UNIVERSITAET ULM	3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT	3
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ	3
UNIVERSITATSKLINIKUM BONN	3
UNIVERSITE DU LUXEMBOURG	3
UNIVERSITEIT MAASTRICHT	3
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER	3
ABBVIE INC	2
ACADEMISCH ZIEKENHUIS LEIDEN	2
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS	2
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN	2
ANAXOMICS BIOTECH S L	2
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS	2
ASTRAZENECA	2
ASTRAZENECA AB	2
AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO	2
BIOTRIAL	2
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE	2
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL	2
CENTRE DE REGULACIO GENOMICA	2
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER	2
CENTRO DE INVESTIGACION BIOMEDICA EN RED	2
CHARLES UNIVERSITY PRAGUE	2
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL	2
COMMISSARIAT A L'ENERGIE ATOMIQUE	2
CONCENTRIS RESEARCH MANAGEMENT	2
CONSIGLIO NAZIONALE DELLE RICERCHE	2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER	2
CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED MP	2
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV	2
EATRIS ERIC	2

Constancy:

Total number of partners: 1038
Partner loyalty:
Frequent Partner: (> 2 projects): 354
Rare Partner: 684
Frequent / Rare Partner Ratio: 0.52

Project overview:

Start date	Project	acronym	role	funding	partners
2021-11-01	European platform for neurodegenerative disorders	EPND	participant	9.680.000	29
2021-07-01	PI3K/PTEN-related monogenic disease to understand cancer	PIPgen	participant	4.099.075	11
2021-06-01	Psychiatric Ratings using Intermediate Stratified Markers 2	PRISM 2	participant	3.980.906	15
2021-06-01	Individualized CARE for Older Persons with Complex Chronic Conditions at home and in nursing homes	I-CARE4OLD	coordinator	5.832.536	14
2021-04-01	Tau Pathology in Alzheimer’s disease: Spreading and Resilience	TAU-NOW	participant	1.500.000	2
2021-04-01	POLYRISK - Understanding human exposure and health hazard of micro- and nanoplastic contaminants in our environment	POLYRISK	participant	5.991.078	15
2021-04-01	Non-coding RNA and Intercellular Communication in Cardiac Ageing	NICCA	coordinator	1.999.690	1
2021-03-01	Training Network for Optimizing Adoptive T cell Therapy of Cancer	T-OP	participant	4.100.959	12
2021-03-01	Anti-Cancer Light-Controllable Antibody-Peptide Conjugates	ALISE	participant	745.200	7
2021-03-01	A multidisciplinary training network for the bioinspired development of glycomimetics tuning the Siglec-Sialoglycan axis	GLYTUNES	participant	3.744.224	11
2021-02-01	Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine	TIGER	participant	6.900.000	8
2021-01-01	Evidence-based co-creation methodology for bridging the implementation gap between knowledge and action in health promotion.	Health CASCADE	participant	4.058.109	7
2021-01-01	Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials	SISAQOL-IMI	participant	2.281.840	33
2021-01-01	Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy	T2EVOLVE	participant	8.728.185	29
2020-12-01	Improving the Preparedness of Health Systems to Reduce Mental Health and Psychosocial Concerns resulting from the COVID-19 Pandemic	RESPOND	participant	6.172.028	17
2020-11-01	Drug discovery screening using human neurons	HumanNeuronScreen	coordinator	150.000	1
2020-10-01	HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS	HARMONY PLUS	participant	6.715.625	41
2020-10-01	Skin Tissue Engineering and Regenerative Medicine: From skin repair to regeneration	SkinTERM	participant	3.192.736	8
2020-07-01	Development of Impentri, an intravenous imatinib formulation for Covid-19 acute respiratory distress syndrome (ARDS).	Impentri	participant	3.662.963	5
2020-06-01	Beyond 1M Genomes	B1MG	participant	4.000.000	37
2020-06-01	Chimeric antigen receptor (CAR) T-cell therapy against solid tumors by targeting the vasculature	AngioCAR	coordinator	175.572	1
2020-05-01	Molecular Imaging of Microglia	MIM	coordinator	175.572	1
2020-04-01	Early Stage Researchers EDUCational Program on Factor VIII Immunogenicity	EDUC8	participant	2.100.702	9
2020-02-01	Molecular mechanism and inhibition of extracellular vesicle-mediated PD-L1 release in melanoma cells	UNPACK PD-L1	coordinator	175.572	1
2020-01-01	Causative mechanisms & integrative models linking early-life-stress to psycho-cardio-metabolic multi-morbidity	EarlyCause	participant	5.997.381	14
2020-01-01	Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research	MATCH	coordinator	150.000	1
2020-01-01	A high-dimensional approach for unwinding immune-metabolic causes of cardiovascular disease-depression multimorbidities	TO_AITION	participant	5.990.515	14
2020-01-01	RISK-BASED SCREENING FOR CERVICAL CANCER	RISCC	coordinator	5.792.355	11
2020-01-01	EXposome Powered tools for healthy living in urbAN SEttings	EXPANSE	participant	11.993.907	20
2019-11-01	Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis	MIRIADE	coordinator	4.015.376	11
2019-10-01	Exploitation of the SECRETory pathway for cancer therapy to address European research	SECRET	participant	3.915.872	12
2019-10-01	Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies	Immune-Image	coordinator	15.000.000	23
2019-09-01	Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions	3TR	participant	40.273.192	70
2019-06-01	Using CRISPR genome screens and dual transcriptome analyses to dissect host-pathogen interactions in tuberculosis	Host-TB	coordinator	2.160.926	2
2019-06-01	Research and Training in Early Life Nutrition to Prevent Disease	GROWTH	participant	2.133.199	8
2019-05-01	ENdoThelial macRophage Alliance In Neuroinflammation	ENTRAIN	participant	3.664.174	20
2019-05-01	Dementia: Intersectorial Strategy for Training and Innovation Network for Current Technology (DISTINCT)	DISTINCT	participant	3.998.048	10
2019-05-01	Saracatinib Trial tO Prevent FOP	STOPFOP	coordinator	999.710	6
2019-03-01	European network staff eXchange for integrAting precision health in the health Care sysTems	ExACT	participant	1.090.200	18
2019-01-01	automatic detection and localization of High frequency Oscillation in Paediatric Epilepsy	HOPE	participant	1.214.400	13
2019-01-01	Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain	IM2PACT	participant	9.000.000	27
2019-01-01	Standard Operating Procedures for Research Integrity	SOPs4RI	participant	3.999.860	13
2019-01-01	CeLac and European consortium for a personalized medicine approach to Gastric Cancer	LEGACy	participant	3.577.431	11
2019-01-01	Identification and Management of Patients at Risk – Outcome and Vascular Events in Peritoneal Dialysis	IMPROVE-PD	participant	3.970.006	23
2019-01-01	Remote Assessment of Disease and Relapse – Alzheimer’s Disease	RADAR-AD	participant	4.999.757	17
2019-01-01	CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease	CardioReGenix	participant	14.839.774	13
2019-01-01	A federated FAIR platform enabling large-scale analysis of high-value cohort data connecting Europe and Canada in personalized health	EUCAN-Connect	participant	5.999.704	13
2018-09-01	PET Imaging of Alpha-Synuclein Fibril Formation	PET-AlphaSy	participant	4.100.370	17
2018-06-01	Virtue based ethics and Integrity of Research: Train-the-Trainer program for Upholding the principles and practices of the European Code of Conduct for Research Integrity	VIRT2UE	coordinator	2.800.000	14
2018-01-01	European Liquid Biopsies Academy - Towards widespread clinical application of blood- based diagnostic tools	ELBA	coordinator	3.727.723	21

overview shows latest 50 from 75 projects (2016-01-01 - 2022-12-31)
A full list of projects can be found here:

STICHTING VUMC -